tiprankstipranks
Biomea Fusion price target lowered to $50 from $60 at Oppenheimer
PremiumThe FlyBiomea Fusion price target lowered to $50 from $60 at Oppenheimer
1M ago
Biomea Fusion announces results from ongoing COVALENT-111 study
Premium
The Fly
Biomea Fusion announces results from ongoing COVALENT-111 study
1M ago
D. Boral maintains Buy rating, $128 target on Biomea Fusion after presentations
Premium
The Fly
D. Boral maintains Buy rating, $128 target on Biomea Fusion after presentations
1M ago
Biomea Fusion price target raised to $19 from $10 at Piper Sandler
PremiumThe FlyBiomea Fusion price target raised to $19 from $10 at Piper Sandler
3M ago
Biomea Fusion Unveils Promising Diabetes Treatment Innovations
Premium
Company Announcements
Biomea Fusion Unveils Promising Diabetes Treatment Innovations
3M ago
Biomea Fusion Reports Q3 2024 Financial Results
Premium
Company Announcements
Biomea Fusion Reports Q3 2024 Financial Results
3M ago
Biomea Fusion announces approval of ‘icovamenib’ as INN for BMF-219
PremiumThe FlyBiomea Fusion announces approval of ‘icovamenib’ as INN for BMF-219
3M ago
Morning Movers: Arcadium Lithium surges after deal to be acquired
Premium
The Fly
Morning Movers: Arcadium Lithium surges after deal to be acquired
3M ago
Biomea Fusion initiated with a Buy at EF Hutton
Premium
The Fly
Biomea Fusion initiated with a Buy at EF Hutton
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100